Ciprofloxacin in the treatment of infections caused by gentamicin-resistant gram-negative bacteria.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D001847:Bone Diseases / Q000188:drug therapy / Q000382:microbiology; D002408:Catheters, Indwelling; D002939:Ciprofloxacin; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D005839:Gentamicins / Q000494:pharmacology; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D006801:Humans; D008826:Microbial Sensitivity Tests; D011446:Prospective Studies; D011552:Pseudomonas Infections / Q000188:drug therapy; D011804:Quinolines / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D011804:Quinolines; D002939:Ciprofloxacin